Pesquisas alternativas:
developp type » developing type (Expandir a Pesquisa), development type (Expandir a Pesquisa), developed ptypei (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
de developp » se developpe (Expandir a Pesquisa), de developing (Expandir a Pesquisa), le developper (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
developp type » developing type (Expandir a Pesquisa), development type (Expandir a Pesquisa), developed ptypei (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
de developp » se developpe (Expandir a Pesquisa), de developing (Expandir a Pesquisa), le developper (Expandir a Pesquisa)
drug doses » drug dose (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
61
Por Wesnes, Keith A.
Publicado em 2000
“... of the core deficits of Alzheimer's disease can be used to screen potential antidernentia drugs. Ultimately...”Publicado em 2000
Obter o texto integral
Obter o texto integral
Artigo
62
Por Laowtammathron, Chuti, Cheng, Eric CH, Cheng, Pei-Hsun, Snyder, Brooke R, Yang, Shang-Hsun, Johnson, Zach, Lorthongpanich, Chanchao, Kuo, Hung-Chih, Parnpai, Rangsun, Chan, Anthony WS
Publicado em 2010
“... model that develops robust pathological features of Huntington's disease would be valuable for drug...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
63
“...Valvular heart diseases (VHDs) are progressive. When not caused by acute comorbidities...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
64
Por Heerboth, Sarah, Lapinska, Karolina, Snyder, Nicole, Leary, Meghan, Rollinson, Sarah, Sarkar, Sibaji
Publicado no Genet Epigenet (2014)
“... disorders, metabolic disorders, and cancer development. Therefore, identifying drugs that inhibit...”Publicado no Genet Epigenet (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
65
“...BACKGROUND. Regulatory approval of oncology drugs is the cornerstone of the development process...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
66
Por Gorter, Kees J, van de Laar, Floris Alexander, Janssen, Paul G H, Houweling, Sebastian T, Rutten, Guy E H M
Publicado em 2012
“...% of the adult population. Type 2 diabetes may occur with obesity, hypertension, and dyslipidaemia (the metabolic...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Artigo
67
Por Sablón-Carrazana, Marquiza, Fernández, Isaac, Bencomo, Alberto, Lara-Martínez, Reyna, Rivera-Marrero, Suchitil, Domínguez, Guadalupe, Pérez-Perera, Rafaela, Jiménez-García, Luis Felipe, Altamirano-Bustamante, Nelly F., Diaz-Delgado, Massiel, Vedrenne, Fernand, Rivillas-Acevedo, Lina, Pasten-Hidalgo, Karina, Segura-Valdez, María de Lourdes, Islas-Andrade, Sergio, Garrido-Magaña, Eulalia, Perera-Pintado, Alejandro, Prats-Capote, Anaís, Rodríguez-Tanty, Chryslaine, Altamirano-Bustamante, Myriam M.
Publicado no PLoS One (2015)
“...The increasing prevalence of conformational diseases, including Alzheimer's disease, type 2...”Publicado no PLoS One (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
68
Por Marijana Radonjic, Peter Y Wielinga, Suzan Wopereis, Thomas Kelder, Varshna S Goelela, Lars Verschuren, Karin Toet, Wim van Duyvenvoorde, Bianca van der Werff van der Vat, Johanna H M Stroeve, Nicole Cnubben, Teake Kooistra, Ben van Ommen, Robert Kleemann
Publicado em 2013-01-01
“...Excess caloric intake leads to metabolic overload and is associated with development of type 2...”Publicado em 2013-01-01
Obter o texto integral
Artigo
69
Por Radonjic, Marijana, Wielinga, Peter Y., Wopereis, Suzan, Kelder, Thomas, Goelela, Varshna S., Verschuren, Lars, Toet, Karin, van Duyvenvoorde, Wim, van der Werff van der Vat, Bianca, Stroeve, Johanna H. M., Cnubben, Nicole, Kooistra, Teake, van Ommen, Ben, Kleemann, Robert
Publicado em 2013
“...Excess caloric intake leads to metabolic overload and is associated with development of type 2...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
70
Por Dalmau, Rosa, Boira, Miriam, Aguilar, Carina, López, Carlos, Rodríguez, Dolors, Gentille, Delicia, Bofill, Domingo, Diogene, Eduard, Pepió, Josep M
Publicado em 2011
“... and time of diagnosis of IHD, type and dose of prescribed cholesterol-lowering drugs, level of physician...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
71
Por Dumbreck, Siobhan, Flynn, Angela, Nairn, Moray, Wilson, Martin, Treweek, Shaun, Mercer, Stewart W, Alderson, Phil, Thompson, Alex, Payne, Katherine, Guthrie, Bruce
Publicado no BMJ (2015)
“...Objective To identify the number of drug-disease and drug-drug interactions for exemplar index...”Publicado no BMJ (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
72
Assuntos:
“...folic acid, MTHFR polymorphisms, folate metabolism, disease risk, drug interaction...”
Obter o texto integral
Obter o texto integral
Artigo
73
“... delay and clonogenic cell survival during repeated drug treatment. A slow rate of resistance development...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
74
“...) developing efficient differentiation strategies to relevant cell types, (5) identifying discernible cellular...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
75
Por Karin, Michael
Publicado em 2005
“...-ending quest to identify novel targets for the rational development of antiinflammatory drugs. The major...”Publicado em 2005
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
76
Por Zhang, Jian-Xin, Wang, Kun, Mao, Zheng-Fa, Fan, Xin, Jiang, De-Li, Chen, Min, Cui, Lei, Sun, Kang, Dang, Sheng-Chun
Publicado em 2013
“... different types and uses of liposomes in the development of therapeutics for gastrointestinal diseases...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
77
“...Antibody drug conjugates (ADCs) are an emerging new class of targeted therapeutics for cancer...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
78
“... specific cell types or functional states within the brain, releasing drugs in a controlled manner...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
79
Por Aflaki, Elma, Stubblefield, Barbara K., Maniwang, Emerson, Lopez, Grisel, Moaven, Nima, Goldin, Ehud, Marugan, Juan, Patnaik, Samarjit, Dutra, Amalia, Southall, Noel, Zheng, Wei, Tayebi, Nahid, Sidransky, Ellen
Publicado em 2014
“... be used to investigate disease pathogenesis and facilitate drug development....”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
80